BIOEN fundamentals
An in-depth look to BIOTREND CEVRE VE ENERJI operating, investing, and financing activities
BIOEN free cash flow for Q3 23 is -62.27 M TRY. For 2022, BIOEN free cash flow was -916.04 M TRY and operating cash flow was -18.61 M TRY.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TRY
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM